Logo image of TRDA

ENTRADA THERAPEUTICS INC (TRDA) Stock Earnings & Estimates

NASDAQ:TRDA - US29384C1080 - Common Stock

5.47 USD
-0.18 (-3.19%)
Last: 8/29/2025, 8:00:01 PM
5.47 USD
0 (0%)
After Hours: 8/29/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
TRDA revenue by date.TRDA revenue by date.
129.013M210.782M
63.38%
39.345M
-81.33%
34.313M
-12.79%
57.548M
67.71%

-100.00%
25.5M
EBITDA
YoY % growth
TRDA ebitda by date.TRDA ebitda by date.
-95.35M
-90.66%
-321K
99.66%
50.784M
15,920.56%
-137.757M
-371.26%
-153.572M
-11.48%
-149.16M
2.87%
N/AN/AN/A
EBIT
YoY % growth
TRDA ebit by date.TRDA ebit by date.
-97.25M
-90.20%
-3.162M
96.75%
47.011M
1,586.75%
-163.037M
-446.81%
-217.614M
-33.48%
-219.421M
-0.83%
-255M
-16.22%
-280.5M
-10.00%
-288.15M
-2.73%
Operating Margin
TRDA operating margin by date.TRDA operating margin by date.
N/A-2.45%22.30%-414.38%-634.20%-381.28%N/AN/A-1,130.00%
EPS
YoY % growth
TRDA eps by date.TRDA eps by date.
-3.02
63.24%
-0.26
91.39%
1.91
834.62%
-3.60
-288.51%
-4.65
-29.18%
-4.25
8.66%
6.18
245.50%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.01
-189.24%
-1.09
-3,738.00%
-1.08
-157.43%
-1.13
-8.37%
-1.16
-14.83%
-1.24
-14.02%
Revenue
Q2Q % growth
9.216M
-52.91%
6.156M
-83.54%
9.489M
-53.84%
4.796M
145.95%
8.196M
-11.07%
8.196M
33.14%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-44.105M
-103.64%
-48.956M
-734.42%
-61.307M
-181.35%
-64.606M
-37.90%
-68.091M
-54.38%
-71.773M
-46.61%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-1.04
-167.10%
-0.86-0.18-20.31%
Q1 2025
Q2Q % growth
-0.42
-161.76%
-0.800.3847.81%
Q4 2024
Q2Q % growth
0.03
110.34%
-0.680.71104.39%
Q3 2024
Q2Q % growth
-0.35
-134.31%
-0.740.3952.87%
Q2 2024
Q2Q % growth
1.55
298.72%
0.151.40948.01%
Q1 2024
Q2Q % growth
0.68
423.81%
-0.611.29212.23%
Q4 2023
Q2Q % growth
-0.29
63.29%
-0.17-0.12-69.23%
Q3 2023
Q2Q % growth
1.02
227.50%
-0.751.77235.92%
Q2 2023
Q2Q % growth
-0.78
-5.41%
-0.70-0.08-10.83%
Q1 2023
Q2Q % growth
-0.21
69.57%
0.99-1.20-121.28%
Q4 2022
Q2Q % growth
-0.79
11.24%
-0.840.056.31%
Q3 2022
Q2Q % growth
-0.80
91.82%
-0.78-0.02-3.20%
Q2 2022
Q2Q % growth
-0.74 -0.740.00-0.21%
Q1 2022
Q2Q % growth
-0.69 -0.67-0.02-3.28%
Q4 2021
Q2Q % growth
-0.89 -1.310.4232.04%
Q3 2021
Q2Q % growth
-9.78 -0.89-8.89-1,002.10%
TRDA Yearly EPS VS EstimatesTRDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.95M
-97.94%
9.844M-7.894M-80.19%
Q1 2025
Q2Q % growth
20.558M
-65.23%
10.374M10.184M98.17%
Q4 2024
Q2Q % growth
37.398M
-10.63%
13.383M24.015M179.44%
Q3 2024
Q2Q % growth
19.57M
-55.25%
12.567M7.003M55.73%
Q2 2024
Q2Q % growth
94.694M
421.16%
46.997M47.697M101.49%
Q1 2024
Q2Q % growth
59.12M
134.05%
15.276M43.844M287.01%
Q4 2023
Q2Q % growth
41.848M 24.169M17.679M73.15%
Q3 2023
Q2Q % growth
43.735M 9.789M33.946M346.78%
Q2 2023
Q2Q % growth
18.17M 9.972M8.198M82.21%
Q1 2023
Q2Q % growth
25.26M 121.38M-96.12M-79.19%
TRDA Yearly Revenue VS EstimatesTRDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2030 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-9.97% -28.62% -11.62% -9.09%
Revenue-3.89% -26.59% -17.55% -2.82%